4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000036
Chief Medical Officer sold 416 shares at $26.53 ($11,036)
- Chief Medical Officer acquired 416 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-07-17 | Option exercise 10b5-1 | +416 | $15.44 | $6,423 | 51,800 | D |
| Rodman David Malcom Chief Medical Officer | 2026-07-17 | Sale 10b5-1 | −416 | $26.53 | $11,036 | 51,384 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-07-17 | Option exercise · Stock Option 10b5-1 | −416 | 3,334 | D | ||
| Open-market sales · 416 sh · avg $26.53 · $11,036 | |||||||
Loading xslF345X06/wk-form4_1784595624.xml…